NewslettersImmunology of Infectious Disease News‘An Unexpected Outcome’: Bavarian Nordic Crashes Out of RSV Race as Vaccine Fails Phase III TrialBy lbeveridge - July 26, 20230180Bavarian Nordic has crashed out of the respiratory syncytial virus (RSV) vaccine race, with a phase III failure in older adults sending the company’s plans—and stock price—into a tailspin.[Fierce Biotech]Press Release